SCHEMBL24047419

SCHEMBL24047419

c1ccc(-c2cccc(N(c3ccc4ccccc4c3)c3ccc4oc5c6ccccc6ccc5c4c3N(c3ccccc3)c3ccc4ccccc4c3)c2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A1 P04798 15/20 0.40
CYP1B1 Q16678 14/20 0.40
CYP1A2 P05177 14/20 0.40
ABCG2 Q9UNQ0 4/20 0.36
PRKDC P78527 3/20 0.36
ABCC1 P33527 2/20 0.36
KDM4E B2RXH2 1/20 0.36
PDE5A O76074 1/20 0.36
ALDH1A1 P00352 1/20 0.36
TP53 P04637 1/20 0.36
ABCB1 P08183 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36
MAPT P10636 1/20 0.36
CYP19A1 P11511 1/20 0.36
CYP2C9 P11712 1/20 0.36
HPGD P15428 1/20 0.36
TSHR P16473 1/20 0.36
CYP2B6 P20813 1/20 0.36
TACR2 P21452 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24048099 0.96 CYP1A1 (0.41) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL24048418 0.96 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL24907913 0.96 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL24048470 0.94 CYP1A1 (0.36) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL24048465 0.90 CYP1A1 (0.39) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL24048087 0.88 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL24907807 0.88 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL24047787 0.87 CYP1A1 (0.38) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL24888686 0.87 CYP1A1 (0.42) CYP1A1CYP1B1CYP1A2ABCG2PRKDC
SCHEMBL24047285 0.87 CYP1A1 (0.37) CYP1A1CYP1B1CYP1A2ABCG2PRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2023-10-19 US disclosed
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2023-10-19 US disclosed
WO-2023003436-A1 ORGANIC LIGHT-EMITTING DEVICE 주식회사 엘지화학 2023-01-26 WO disclosed
WO-2021235830-A1 NOVEL COMPOUND AND ORGANIC LIGHT-EMITTING ELEMENT COMPRISING SAME 주식회사 엘지화학 2021-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230337531-A1 NOVEL COMPOUNDS AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME CRY1, AHR, CRY2 CYP1A1 21/4885CYP1B1 51/4885CYP1A2 127/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.